Increasing tfr1 palmitoylation as a novel therapeutic strategy for

The present invention relates to methods and pharmaceutical compositions for the treatment of neurodegeneration with brain iron accumulation (NBIA). […]

Plga microparticles loaded with a fluoroquinolone forthe treatment of

This invention relates to:- PLGA (poly lactic-co-glycolic acid, i.e. a copolymer of poly lactic acid (PLA) and poly glycolic acid) microparticles […]

Direct pulmonary delivery of oseltamivir carboxylate for the treatment

The present application relates to antiviral compounds and to their use for the treatment and/or prevention of viral infections.More particularly, the […]

Product combination for the treatment of filovirus infections

The present invention relates to methods and pharmaceutical compositions for the treatment of filovirus infections. Although several antivirals have […]

A progression model that estimates a normative scenario of the

The invention relates to age-related brain diseases, such as Parkinson’s or Alzheimer’s disease. Statistical models based on the regression of […]

Nano-sized drug delivery structure

The present invention relates to a nano-sized drug delivery structure for delayed and controlled diffusion of at least one drug active, in particular […]

Method for universal detection and quantification of mycoplasma

The present invention relates to a method for detecting mycoplasma 16S rDNA 1.5 kilobase fragment amplified quantitative polymerase chain reaction […]

Apelin receptor agonist for the treatment of post-operative cognitive

The present invention relates to methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction. In particular, the […]

Reduction of carcinomatosis risk using icodextrin as a carrier

The present invention relates to methods and pharmaceutical compositions for the prophylactic treatment of peritoneal carcinomatosis. In particular, […]

Factor h fragment for use as an anti-angiogenic agent

The invention relates to a complement factor H fragment for use in the therapy and/or prophylaxis of a disease involving neovascularization.POC in […]